Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers
Seagen Inc.
Seagen Inc.
Jazz Pharmaceuticals
Elicio Therapeutics
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Elevation Oncology
EMD Serono
EMD Serono
Sanofi
INSYS Therapeutics Inc